Team Business Headline
Business Headline is a digital news media organisation which covers news related to Business and Stock Market and Technology related news.
BOSS Zhipin Continues Share Repurchases: More than RMB340M in 2026 Under Buyback Program
BEIJING, Feb. 20, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin”or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing near RMB25 million to repurchase 410,642 ordinary shares on Feb 17 and Feb 18. In 2026, the Company has deployed more than RMB340 million toward share repurchases. This move underscores the Company's ongoing commitment...
NOVONIX Appoints Michael O’Kronley as Chief Executive Officer
CHATTANOOGA, Tenn., April 27, 2025 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials...
Perseus Mining Proceeds with Development of Nyanzaga Gold Project
Perth, April 28, 2025 (GLOBE NEWSWIRE) -- PERSEUS MINING PROCEEDS WITH DEVELOPMENT OF THE NYANZAGA GOLD PROJECT overview Perth, Western...
Alkane and Mandalay Combine to Create Growing Gold and Antimony Producer
Merger of Equals Increases Scale and Benefits All ShareholdersCreates powerful platform underpinned by a shared vision for growth.Three cash-generating mines in premier mining jurisdictions...
BDTCOIN (BDTC) Is Listed On AscendEX! Trade Now!
FERNANDINA BEACH, Fla., April 27, 2025 (GLOBE NEWSWIRE) -- BDTCOIN, the world’s first gold-backed...
XRP News: XploraDEX $XPL Presale Nears Completion as Final Countdown 48 Hours Begins
ZURICH, April 26, 2025 (GLOBE NEWSWIRE) -- The final 48 hours are here, The XploraDEX $XPL Presale, the gateway to XRPL’s first...
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological...
- Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003 Cohort C – - 58.3% of patients showed...
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer...
FOMO Builds As Bitcoin Briefly Shoots Above $94K; Investors Shift To Earn BTC Through Zaminer Cloud Mining Site
Middlesex, UK , April 26, 2025 (GLOBE NEWSWIRE) -- On April 23, the total cryptocurrency market cap jumped by 1%, briefly...
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public...
A.I.S. Resources Closes Non-Brokered Private Placement
VANCOUVER, British Columbia, April 25, 2025 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces...
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new...
17 Education & Technology Group Inc. Files Its Annual Report on Form 20-F
BEIJING, April 25, 2025 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education...